Cartagen Molecular Systems

Cartagen Molecular Systems was a biotechnology company focused on developing advanced molecular analysis and diagnostic technologies. The company's core innovation was the Masscode system, a high-throughput platform that used mass spectrometry-cleavable tags for the multiplexed detection of nucleic acids. This technology allowed for the simultaneous analysis of numerous genetic markers, significantly enhancing the speed and accuracy of genomic research and clinical testing. In 1998, the company was acquired by Qiagen, which integrated the Masscode technology into its portfolio of molecular biology reagents and diagnostic tools. The acquisition allowed Qiagen to expand its presence in the emerging field of molecular diagnostics and high-throughput genomics.